Step on it !25 Dec 2020 10:09
Mologic Receives CE Mark Approval for Professional-Use COVID-19 Rapid Antigen Test
Previous
Preliminary results show 92% sensitivity and 100% specificity, compared with RT-PCR
Bedfordshire, UK, 24 December 2020: Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, is pleased to announce its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM). The test will provide health professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs, within 10 minutes. Development and validation were supported by the Wellcome Trust and the Foreign, Commonwealth and Development Office (FCDO) Joint Initiative on Research in Epidemic Preparedness and Response.